With an average of 41% of molecular diagnostic (MDx) test claims being denied by Medicare Part B contractors, it’s critical that clinical laboratories use the correct codes and know when and how to appeal when claims are denied.
Please join Laboratory Economics and host Kimberly Scott for a 75-minute conference call where two industry experts, Charles Root with CodeMap, and Rina Wolf with XIFIN Inc., will provide an update on the latest in MDx coding and billing for 2016.
Vice President, Commercialization Strategies, Consulting & Industry Affairs
Laboratory Economics is the brainchild of Jondavid Klipp, a nationally recognized expert on the business of laboratory medicine. His research has appeared in numerous business and trade publications including the Wall Street Journal, New York Times and Medical Laboratory Observer.